β-D-Galactopyranoside, 6-fluoro-1H-indol-3-yl – (207727-11-5)

sisomicin, Rickamicin, 32385-11-8, Sisomycin, Sissomicin, Antibiotic 6640, Antibiotic 66-40, Sisomicina, Sisomicine, Sch 13475, Sisomicinum, Dehydrogentamicin Cla, Sisomicine [INN-French], Sisomicinum [INN-Latin], Sisomicina [INN-Spanish], Sch-13475, EINECS 251-018-2, X55XSL74YQ, Sisomicin [USAN:INN:BAN], Sch13475, BRN 1357913, CHEBI:9169, 4, 5 Dehydrogentamicin, SISOMICIN [INN], SISOMICIN [MI], SISOMICIN [USAN], SISOMICIN [WHO-DD], (2R, 3R, 4R, 5R)-2-[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[[(2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3, 5-diol, D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2, 6-diamino-2, 3, 4, 6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-, Sisomin, O-2, 6-Diamino-2, 3, 4, 6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-2-deoxy-D-streptamine, Sizomycin, Sisomicine (INN-French), Sisomicinum (INN-Latin), Sisomicina (INN-Spanish), (1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[(2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yloxy]-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside, (2S-cis)-4-O-(3-Amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl)-2-deoxy-6-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl)-D-streptamine, GENTAMICIN SULFATE IMPURITY A [EP IMPURITY], O-2, 6-Diamino-2, 3, 4, 6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy-D-streptamine, 4, 5-Dehydrogentamicin, Salvamina, Siseptin sulfate, (1s, 2s, 3r, 4s, 6r)-4, 6-Diamino-3-{[(2s, 3r)-3-Amino-6-(Aminomethyl)-3, 4-Dihydro-2h-Pyran-2-Yl]oxy}-2-Hydroxycyclohexyl 3-Deoxy-4-C-Methyl-3-(Methylamino)-Beta-L-Arabinopyranoside, (2R, 3R, 4R, 5R)-2-(((1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-(((2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3, 5-diol, (2R, 3R, 4R, 5R)-2-[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[[3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3, 5-diol, (2S-CIS)-4-O-(3-AMINO-6-(AMINOMETHYL)-3, 4-DIHYDRO-2H-PYRAN-2-YL)-2-DEOXY-6-O-(3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA.-L-ARABINOPYRANOSYL)-D-STREPTAMINE, 2-DEOXY-4-O-(3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA.-L-ARABINOPYRANOSYL)-6-O-(2, 6-DIAMINO-2, 3, 4, 6-TETRADEOXY-.ALPHA.-D-GLYCERO-HEX-4-ENOPYRANOSYL)-L-STREPTAMINE, O-3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA-L-ARABINOPYRANOSYL-(1->4)-O-(2, 6-DIAMINO-2, 3, 4, 6-TETRADEOXY-.ALPHA.-D-GLYCERO-HEX-4-ENOPYRANOSYL-(1->6))-2-DEOXY-L-STREPTAMINE, GENTAMICIN SULFATE IMPURITY A (EP IMPURITY), UNII-X55XSL74YQ, DTXSID0023583, sisomicin-sulfate, (1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-((2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside, (2R, 3R, 4R, 5R)-2-(((1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-(((2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)oxane-3, 5-diol, (2R, 3R, 4R, 5R)-2-((1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-(((2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy-5-methyl-4-(methylamino)oxane-3, 5-diol, (2R, 3R, 4R, 5R)-2-((1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-((3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy-5-methyl-4-(methylamino)oxane-3, 5-diol, (2R, 3R, 4R, 5R)-2-{[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-{[(2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3, 5-diol, SiS, Sisomicin (USAN/INN), SCHEMBL49395, O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-4)-O-(2, 6-diamino-2, 3, 4, 6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-6))-2-deoxy-L-streptamine, CHEMBL221886, GTPL10858, HY-B1222A, J01GB08, DTXCID301508648, AKOS015895179, AS27839, DB12604, DA-67611, CS-0013807, NS00011534, C00494, D02544, G78298, NETILMICIN SULFATE IMPURITY A [EP IMPURITY], Q3962119, (2R, 3R, 4R, 5R)-2-[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[[(2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3, 5-diol, 2-DEOXY-4-O-(3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-BETA-L-ARABINOPYRANOSYL)-6-O-(2, 6-DIAMINO-2, 3, 4, 6-TETRADEOXY-ALPHA-D-GLYCERO-HEX-4-ENOPYRANOSYL)-L-STREPTAMINE, 251-018-2, O-3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA-L-ARABINOPYRANOSYL-(1->4)-O-(2, 6-DIAMINO-2, 3, 4, 6-TETRADEOXY-ALPHA-D-GLYCERO-HEX-4-ENOPYRANOSYL-(1->6))-2-DEOXY-L-STREPTAMINE, O-3-Deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1-6)-O-[2, 6-diamino-2, 3, 4, 6-tetradeoxy-a-D-glycero-hex-4-enopyranosyl-(1- 4)]-2-deoxy- D-streptamine Antibiotic 66-40 Antibiotic 6640